Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.
2 reports, 2 independent
Updated 00:00
Still developing
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies and TD Cowen added to the coverage of Freenome by Leerink Partners.1 source
Leerink Partners initiated coverage and set price targets for Freenome.1 source
Keep exploring
The entities involved
-
Leerink partners
U.S. investment bank
Related events
- Leerink Partners began coverage on Novogen Limited shares on October 20, 2026.
- Leerink Partners reduced its target price for Keros Therapeutics on November 2, 2026.
- Leerink Partners and Barclays raised price targets on Elevance Health, while MarketBeat reported consensus ratings.
- Leerink Partners decreased its target price on CVS Health, while BNP Paribas and Wyoming increased their holdings.